PEGS Boston


Monday, August 31, 2020 - Friday, September 4, 2020


PEGS Boston attendee using laptop


We have been notified that the 16th Annual PEGS Boston is now virtual. If you were scheduled to meet with our team, someone will be in touch with you to determine if you’d like to proceed with a virtual discussion. Please contact [email protected] with any questions.

Join us at the 16th Annual PEGS Boston: The Essential Protein Engineering & Cell Therapy Summit. With several programs and over 350 speakers at this year’s event, it will cover everything from oncology and immunotherapy to bioconjugates and emerging therapeutics. Experts from top pharma, biotech, academic, and government institutions will share how developments in biotherapeutics will impact current and future research.

We’re proud to sponsor two presentations at this year’s event:

Tuesday, September 1, 2020, 9:45 AM EDT
Discovering Potently Neutralizing COVID-19 Therapeutic Antibodies, A Case Study and Expert Q&A Session | Katherine Vousden, Science Director, Large Molecule, Charles River and Jake Glanville, Chief Executive Officer and Founding Partner, Distributed Bio

Thursday, September 3, 2020, 1:25 PM EDT
A Platform Approach for Analytical Methods to Support Adeno-Associated Virus (AAV) Gene Therapy Products | Yan Zhi, Director Scientific Services, Charles River

We will also be participating in this poster session:

First-in-Class Meets Best-in-Class: Rapid Antibody Discovery on Hard Targets Combined with Fine-Grained Engineering and Optimization  | Sarah Ives, Director of Contract Research, Distributed Bio

If you’d like to request a virtual meeting, contact [email protected].